Differential TLR7-mediated cytokine expression by R848 in M-CSF- versus GM-CSF-derived macrophages after LCMV infection.
Animals
Cell Differentiation
Cells, Cultured
Cytokines
/ biosynthesis
Granulocyte-Macrophage Colony-Stimulating Factor
/ immunology
Imidazoles
/ pharmacology
Lymphocytic choriomeningitis virus
/ physiology
Macrophage Colony-Stimulating Factor
/ immunology
Macrophages
/ immunology
Membrane Glycoproteins
/ metabolism
Mice
Mice, Inbred C57BL
Signal Transduction
Toll-Like Receptor 7
/ metabolism
GM-CSF
M-CSF
R848
TLR7
cytokines
macrophages
Journal
The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
18
12
2020
medline:
17
7
2021
entrez:
17
12
2020
Statut:
ppublish
Résumé
Granulocyte-macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) play an important role in macrophage (MФ) development by influencing their differentiation and polarization. Our goal was to explore the difference between M-CSF- and GM-CSF-derived bone marrow MФ responsiveness to TLR7-mediated signalling pathways that influence cytokine production early after infection in a model of acute virus infection. To do so, we examined cytokine production and TLR7-mediated signalling at 1 h post-lymphocytic choriomeningitis virus (LCMV) Armstrong (ARM) infection. We found that R848-induced cytokine expression was enhanced in these cells, with GM-CSF cells exhibiting higher proinflammatory cytokine expression and M-CSF cells exhibiting higher anti-inflammatory cytokine expression. However, R848-mediated signalling molecule activation was diminished in LCMV-infected M-CSF and GM-CSF macrophages. Interestingly, we observed that TLR7 expression was maintained during LCMV infection of M-CSF and GM-CSF cells. Moreover, TLR7 expression was significantly higher in M-CSF cells compared to GM-CSF cells. Taken together, our data demonstrate that although LCMV restrains early TLR7-mediated signalling, it primes differentiated MФ to enhance expression of their respective cytokine profiles and maintains levels of TLR7 expression early after infection.
Identifiants
pubmed: 33331816
doi: 10.1099/jgv.0.001541
pmc: PMC8515861
doi:
Substances chimiques
Cytokines
0
Imidazoles
0
Membrane Glycoproteins
0
Tlr7 protein, mouse
0
Toll-Like Receptor 7
0
Macrophage Colony-Stimulating Factor
81627-83-0
Granulocyte-Macrophage Colony-Stimulating Factor
83869-56-1
resiquimod
V3DMU7PVXF
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Front Immunol. 2019 Sep 04;10:2055
pubmed: 31552022
Cell Host Microbe. 2011 Dec 15;10(6):534-9
pubmed: 22177558
Nat Med. 2004 May;10(5):540-4
pubmed: 15107845
Cell Host Microbe. 2012 Jun 14;11(6):643-53
pubmed: 22704624
Methods Mol Biol. 2009;531:29-43
pubmed: 19347309
Cytokine. 2020 Mar;127:154939
pubmed: 31786501
Cell Host Microbe. 2012 May 17;11(5):481-91
pubmed: 22607801
Immunol Cell Biol. 2011 Feb;89(2):283-93
pubmed: 20661257
Immunity. 2015 Jun 16;42(6):1197-211
pubmed: 26084029
J Leukoc Biol. 2006 Dec;80(6):1298-307
pubmed: 16905575
Immunobiology. 2014 Oct;219(10):737-45
pubmed: 24954891
F1000Prime Rep. 2014 Mar 03;6:13
pubmed: 24669294
J Leukoc Biol. 2009 Aug;86(2):411-21
pubmed: 19406830
mBio. 2013 Jun 18;4(3):e00264-13
pubmed: 23781069
Mol Cells. 2016 Oct;39(10):734-741
pubmed: 27788572
J Immunol Methods. 2008 Sep 30;338(1-2):47-57
pubmed: 18675819
Proc Natl Acad Sci U S A. 2006 Feb 7;103(6):1828-33
pubmed: 16446426
Genes Immun. 2001 Oct;2(6):349-55
pubmed: 11607792
Mediators Inflamm. 2013;2013:264260
pubmed: 24191131
Nat Immunol. 2019 Apr;20(4):397-406
pubmed: 30742078
Nat Struct Biol. 2003 Nov;10(11):913-21
pubmed: 14555996
BMC Infect Dis. 2012 Jan 14;12:5
pubmed: 22243920
Front Immunol. 2017 Nov 30;8:1629
pubmed: 29250063
Respir Res. 2018 Jan 05;19(1):3
pubmed: 29304863
AIDS. 2008 Mar 30;22(6):685-94
pubmed: 18356597
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
J Immunol. 2007 Apr 15;178(8):5245-52
pubmed: 17404308
Mol Biol Cell. 2007 Nov;18(11):4493-507
pubmed: 17761532
J Virol. 2001 Jan;75(1):448-57
pubmed: 11119613
PLoS One. 2012;7(5):e37337
pubmed: 22615984
Cell Res. 2009 Aug;19(8):973-83
pubmed: 19381167
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
J Leukoc Biol. 2009 Apr;85(4):664-72
pubmed: 19164128
J Immunol. 2005 Apr 1;174(7):3920-4
pubmed: 15778347
Nat Immunol. 2002 Feb;3(2):196-200
pubmed: 11812998
Semin Immunol. 2004 Feb;16(1):3-9
pubmed: 14751757
J Clin Invest. 2012 Mar;122(3):787-95
pubmed: 22378047
Transl Res. 2018 Jan;191:64-80
pubmed: 29175267
Science. 2001 Jul 13;293(5528):253-6
pubmed: 11452116
J Virol. 2008 Jan;82(1):196-206
pubmed: 17942529
Int J Hematol. 2002 Jul;76(1):27-34
pubmed: 12138892
J Biol Chem. 2005 Mar 4;280(9):8617-27
pubmed: 15611045
Nat Rev Immunol. 2008 Jul;8(7):533-44
pubmed: 18551128
Front Immunol. 2017 Sep 04;8:1075
pubmed: 28928743
Curr Top Microbiol Immunol. 2003;276:125-44
pubmed: 12797446
J Immunol. 2012 Jun 1;188(11):5752-65
pubmed: 22547697
Viral Immunol. 2020 Jul/Aug;33(6):477-488
pubmed: 32255741